These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 13987334
1. Management of myasthenia gravis. SCHWAB RS. N Engl J Med; 1963 Mar 14; 268():596-7 contd. PubMed ID: 13987334 [No Abstract] [Full Text] [Related]
2. [DRUG THERAPY OF MYASTHENIA GRAVIS]. SKINHOJ E. Nord Med; 1964 Feb 27; 71():277-9. PubMed ID: 14118993 [No Abstract] [Full Text] [Related]
3. NEONATAL MYASTHENIA GRAVIS. STERN GM, HALL JM, ROBINSON DC. Br Med J; 1964 Aug 01; 2(5404):284-6. PubMed ID: 14160211 [No Abstract] [Full Text] [Related]
4. Report of a case of myasthenia gravis. BRYAN FA. J Indiana State Med Assoc; 1956 Mar 01; 49(3):257-8. PubMed ID: 13306994 [No Abstract] [Full Text] [Related]
5. MYASTHENIA gravis. Br Med J; 1956 Jun 02; 1(4978):1283-4. PubMed ID: 13316135 [No Abstract] [Full Text] [Related]
6. Grob on myasthenia gravis. KAHN A. J Ark Med Soc; 1963 Jan 02; 59():317-8. PubMed ID: 13958281 [No Abstract] [Full Text] [Related]
7. The relative merits of prostigmin and mestinon in the treatment of myasthenia gravis. GUINENA YH, NABI SA, TAHER Y. J Egypt Med Assoc; 1956 Jun 21; 39(3):240-51. PubMed ID: 13367321 [No Abstract] [Full Text] [Related]
8. Treatment of myasthenia gravis; prolonged action with multiple-dose tablets of neostigmine bromide and mestinon bromide. SCHWAB RS, OSSERMAN KE, TETHER JE. J Am Med Assoc; 1957 Oct 12; 165(6):671-4. PubMed ID: 13462827 [No Abstract] [Full Text] [Related]
9. [MYASTHENIA OF OPHTHALMOPLEGIC FORM. REMARKABLE IMPROVEMENT WITH SPIROLACTONES]. CREMIEUX A, BOUDOURESQUES J, BILLE J. Rev Otoneuroophtalmol; 1963 Oct 12; 35():110-3. PubMed ID: 14074785 [No Abstract] [Full Text] [Related]
10. [Case of myasthenia gravis]. KATILA O, KIVALO E. Duodecim; 1955 Oct 12; 71(4):605-10. PubMed ID: 14391241 [No Abstract] [Full Text] [Related]
11. Determination of neostigmine and pyridostigmine in the urine of patients with myasthenia gravis. NOWELL PT, SCOTT CA, WILSON A. Br J Pharmacol Chemother; 1962 Jun 12; 18(3):617-24. PubMed ID: 14480648 [Abstract] [Full Text] [Related]
12. Urecholine in myasthenia gravis. SCHWARZ H. Can Med Assoc J; 1955 Mar 01; 72(5):346-51. PubMed ID: 14352096 [No Abstract] [Full Text] [Related]
13. PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF MYASTHENIA GRAVIS. SCHWAB RS. Med Clin North Am; 1963 Nov 01; 47():1511-24. PubMed ID: 14078160 [No Abstract] [Full Text] [Related]
14. THE EFFECT OF INSULIN AND POTASSIUM IN MYASTHENIA GRAVIS. FRENKEL M. Arch Neurol; 1963 Nov 01; 9():447-57. PubMed ID: 14057677 [No Abstract] [Full Text] [Related]
15. [Changes of cardiac activity of myasthenic patients during the use of anti-cholinesterase preparations (oxazil and proserine)]. IOFFE LA, ANOKHIN LA, KOMAROV BD. Ter Arkh; 1962 Dec 01; 34():99-104. PubMed ID: 13956631 [No Abstract] [Full Text] [Related]
16. [MYASTHENIC SYNDROMES]. DISTEFANO R. Prensa Med Argent; 1963 Jun 28; 50():2021-4. PubMed ID: 14090057 [No Abstract] [Full Text] [Related]
17. [TREATMENT OF MYASTHENIA]. GIULIANI G. Minerva Med; 1964 Jan 27; 55():238-41. PubMed ID: 14144853 [No Abstract] [Full Text] [Related]
18. [Myasthenia gravis]. Gajdos P. Rev Prat; 2002 Jan 01; 52(1):71-7. PubMed ID: 11852770 [No Abstract] [Full Text] [Related]
19. [Current trends in medical and surgical treatment of myasthenia gravis with persistence of the thymus and long-term results of some operated cases]. Sunseri S, Sottosanti M, Spinelli P. Arch Chir Torac Cardiovasc; 1970 Jan 01; 26(1):19-34. PubMed ID: 5477673 [No Abstract] [Full Text] [Related]